Key Insights

The global apheresis equipment market, valued at $3.52 billion in 2025, is projected to experience robust growth, driven by increasing prevalence of chronic diseases requiring apheresis procedures, advancements in apheresis technology, and rising healthcare expenditure globally. The market's Compound Annual Growth Rate (CAGR) of 5.63% from 2025 to 2033 signifies substantial expansion opportunities. Key drivers include the growing geriatric population susceptible to conditions like renal and hematological disorders, the increasing adoption of minimally invasive procedures, and the development of sophisticated, automated apheresis devices. Technological advancements, such as improved membrane separation techniques and automated centrifugation systems, are further boosting market growth. Segment-wise, devices and disposables constitute significant market shares, with leukapheresis and plasmapheresis dominating the apheresis procedure segment. Geographically, North America and Europe currently hold significant market shares due to advanced healthcare infrastructure and high adoption rates, but the Asia-Pacific region is expected to witness substantial growth owing to increasing awareness, rising disposable incomes, and improving healthcare facilities. However, high equipment costs and stringent regulatory approvals pose challenges to market expansion.

Despite these challenges, the apheresis equipment market is poised for significant growth, fueled by the continuous rise in chronic diseases and the ongoing development of innovative apheresis technologies. The increasing focus on personalized medicine and targeted therapies further contributes to the market's expansion. Companies are strategically focusing on developing technologically advanced and user-friendly devices, expanding their geographical reach, and forming strategic partnerships to consolidate their market position. Competition is fierce, with major players like Fresenius Kabi AG, Terumo BCT Inc, and Haemonetics Corporation leading the market. Future market trends point towards a growing demand for portable and point-of-care apheresis systems, as well as increased integration of digital technologies for remote monitoring and data management. The market's trajectory suggests a future characterized by improved efficacy, reduced procedural times, and increased accessibility of apheresis therapies globally.

This comprehensive report provides a detailed analysis of the Apheresis Equipment market, encompassing market size, growth drivers, challenges, and opportunities from 2019 to 2033. The report segments the market by product (Devices, Disposables), apheresis procedure (Leukapheresis, Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Other Apheresis Procedures), technology (Centrifugation, Membrane Separation), and application (Renal Disorders, Hematological Disorders, Neurological Disorders, Autoimmune Disorders, Other Applications). Key players such as Fresenius SE & Co KGAA (Fresenius Kabi AG), Terumo Corporation (Terumo BCT Inc), and Haemonetics Corporation are profiled, providing insights into their market share, strategies, and recent developments. The report utilizes data from the historical period (2019-2024), base year (2025), and estimated year (2025) to forecast market trends through 2033.

Apheresis Equipment Market Concentration & Innovation

The Apheresis Equipment market exhibits a moderately concentrated landscape, with a few major players holding significant market share. Fresenius Kabi AG, Terumo BCT Inc, and Haemonetics Corporation are among the dominant players, collectively accounting for approximately xx% of the global market in 2024. Market concentration is influenced by factors such as high capital investment requirements for R&D, stringent regulatory approvals, and the need for specialized expertise.

Innovation within the market is driven by the demand for improved efficiency, reduced procedural time, and enhanced patient safety. Key innovations include the development of automated systems, advanced membrane technologies, and improved disposables. Regulatory frameworks, primarily driven by agencies like the FDA and EMA, play a vital role in shaping product development and market entry. The market also witnesses continuous efforts to develop substitute technologies, aiming to improve the cost-effectiveness and accessibility of apheresis procedures. Mergers and acquisitions (M&A) are also a key trend, with larger players actively acquiring smaller companies to expand their product portfolios and geographical reach. Recent M&A activities have involved deals with values ranging from xx Million to xx Million, primarily focused on enhancing technological capabilities and market access.

• Market Share: Fresenius Kabi AG: xx%; Terumo BCT Inc: xx%; Haemonetics Corporation: xx%; Others: xx% (2024 estimates)
• M&A Activity: Significant deals reported in the past five years with values ranging from xx Million to xx Million. Focus on technology acquisition and geographical expansion.
• Regulatory Landscape: Stringent regulatory requirements for device approvals and procedural standardization.

Apheresis Equipment Market Industry Trends & Insights

The Apheresis Equipment market is projected to witness robust growth, with a CAGR of xx% during the forecast period (2025-2033). This growth is primarily driven by the increasing prevalence of chronic diseases such as renal and hematological disorders, rising demand for advanced medical treatments, and technological advancements leading to improved efficacy and safety of apheresis procedures. Technological disruptions, particularly the advent of automated systems and advanced membrane separation techniques, are significantly impacting market dynamics, leading to improved efficiency and reduced procedural times. Consumer preferences are shifting towards minimally invasive procedures with shorter recovery times, driving innovation in device design and procedural techniques. The competitive landscape is characterized by intense competition among established players and emerging companies, leading to continuous product innovation and strategic partnerships. Market penetration of automated systems is steadily increasing, particularly in developed regions, while disposables are witnessing high demand driven by safety and convenience factors.

Dominant Markets & Segments in Apheresis Equipment Market

The North American region currently dominates the Apheresis Equipment market, driven by high healthcare expenditure, advanced healthcare infrastructure, and a large patient pool suffering from chronic diseases. Within the product segment, Devices hold the largest market share, owing to the high demand for sophisticated equipment capable of performing various apheresis procedures. Among the apheresis procedures, Plasmapheresis enjoys significant market dominance due to its wide applications in treating various autoimmune disorders. Centrifugation technology continues to hold a dominant position compared to membrane separation, mainly due to its widespread adoption and established clinical efficacy. Renal disorders are a major application segment, fueling demand for apheresis equipment.

• Key Drivers for North American Dominance:

  • High healthcare spending
  • Advanced healthcare infrastructure
  • High prevalence of chronic diseases
  • Strong regulatory support for advanced medical technologies

• Segment Dominance Analysis: Devices (xx% Market Share in 2024), Plasmapheresis (xx% Market Share in 2024), Centrifugation Technology (xx% Market Share in 2024), Renal Disorders (xx% Market Share in 2024).

Apheresis Equipment Market Product Developments

Recent product developments focus on enhancing the efficiency, safety, and portability of apheresis equipment. Automated systems with integrated monitoring and control features are gaining popularity. The introduction of disposables reduces the risk of cross-contamination and simplifies the workflow. Miniaturized devices with improved portability are being developed to expand access to apheresis treatment in remote areas and developing countries. These developments reflect the ongoing trend toward minimally invasive, user-friendly, and cost-effective apheresis solutions tailored to specific clinical needs.

Report Scope & Segmentation Analysis

This report comprehensively analyzes the Apheresis Equipment market across several key segments:

By Product: Devices (including automated and manual systems) and Disposables (e.g., tubing sets, filters). The Devices segment is expected to dominate, driven by technological advancements and improved efficiency.

By Apheresis Procedure: Leukapheresis, Plasmapheresis, Plateletpheresis, Erythrocytapheresis, and Other Apheresis Procedures. Plasmapheresis currently holds the largest share.

By Technology: Centrifugation and Membrane Separation. Centrifugation technology continues to dominate due to established usage.

By Application: Renal Disorders, Hematological Disorders, Neurological Disorders, Autoimmune Disorders, and Other Applications. Renal Disorders currently hold the highest market share.

Each segment's growth projections are detailed in the full report, with analysis of market sizes and competitive dynamics.

Key Drivers of Apheresis Equipment Market Growth

The Apheresis Equipment market is experiencing substantial growth driven by several factors:

• Rising Prevalence of Chronic Diseases: The increasing incidence of renal failure, autoimmune disorders, and hematological malignancies is driving demand for apheresis procedures.
• Technological Advancements: Automated systems, improved disposables, and advanced membrane separation technologies are enhancing efficiency and safety.
• Favorable Regulatory Environment: Regulatory support for innovative medical technologies is fostering market growth.

Challenges in the Apheresis Equipment Market Sector

The Apheresis Equipment market faces challenges including:

• High Initial Investment Costs: The high cost of purchasing and maintaining advanced apheresis equipment can limit market penetration in certain regions.
• Stringent Regulatory Approvals: The rigorous regulatory approval processes for new devices can delay market entry and increase development costs.
• Competition from Established Players: Intense competition among established players is creating pricing pressures and influencing market dynamics.

Emerging Opportunities in Apheresis Equipment Market

Emerging opportunities in the Apheresis Equipment market include:

• Expanding into Emerging Markets: Untapped potential exists in developing countries with rising healthcare expenditure and increasing prevalence of target diseases.
• Development of Point-of-Care Devices: Portable and user-friendly devices can increase access to apheresis treatments in remote areas.
• Integration with Telemedicine: Remote monitoring and data management capabilities can improve treatment outcomes and reduce costs.

Leading Players in the Apheresis Equipment Market Market

• Fresenius SE & Co KGAA (Fresenius Kabi AG)
• Terumo Corporation (Terumo BCT Inc)
• Asahi Kasei Corporation
• Kaneka Corporation
• Sumitomo Bakelite Company Limited (Kawasumi Laboratories Inc)
• Cerus Corporation
• Macopharma SA
• Haemonetics Corporation
• Otsuka Holdings Co Ltd (JIMRO Co Ltd)
• Baxter International
• Medica SPA
• B Braun SE

Key Developments in Apheresis Equipment Market Industry

• June 2022: Terumo Blood and Cell Technologies reported that the UK's NHS England has selected the automated red blood cell exchange (RBCX) procedure performed on the company's Spectra Optia Apheresis System through the NHS MedTech Funding Mandate (MTFM) to treat sickle cell disease. This decision will lead to wider deployment of Spectra Optia in hospitals across England, improving access to treatment for sickle cell disease patients.
• July 2022: Terumo Blood and Cell Technologies collaborated with Eliaz Therapeutics in the development and commercialization of a novel therapeutic apheresis treatment for acute kidney injury (AKI).

Strategic Outlook for Apheresis Equipment Market Market

The Apheresis Equipment market is poised for significant growth, driven by technological innovation, increasing prevalence of target diseases, and expanding access to healthcare in developing countries. Strategic investments in R&D, strategic partnerships, and expansion into new markets will be crucial for success in this dynamic landscape. The focus will remain on developing advanced, cost-effective, and user-friendly apheresis equipment to meet the growing global demand.

Apheresis Equipment Market Segmentation

• 1. Product
  • 1.1. Devices
  • 1.2. Disposables
• 2. Apheresis Procedure
  • 2.1. Leukapheresis
  • 2.2. Plasmapheresis
  • 2.3. Plateletpheresis
  • 2.4. Erythrocytapheresis
  • 2.5. Other Apheresis Procedures
• 3. Technology
  • 3.1. Centrifugation
  • 3.2. Membrane Separation
• 4. Application
  • 4.1. Renal Disorders
  • 4.2. Hematological Disorders
  • 4.3. Neurological Disorders
  • 4.4. Autoimmune Disorders
  • 4.5. Other Applications

Apheresis Equipment Market Segmentation By Geography

• 1. North America
  • 1.1. United States
  • 1.2. Canada
  • 1.3. Mexico
• 2. Europe
  • 2.1. Germany
  • 2.2. United Kingdom
  • 2.3. France
  • 2.4. Italy
  • 2.5. Spain
  • 2.6. Rest of Europe
• 3. Asia Pacific
  • 3.1. China
  • 3.2. Japan
  • 3.3. India
  • 3.4. Australia
  • 3.5. South Korea
  • 3.6. Rest of Asia Pacific
• 4. Middle East and Africa
  • 4.1. GCC
  • 4.2. South Africa
  • 4.3. Rest of Middle East and Africa
• 5. South America
  • 5.1. Brazil
  • 5.2. Argentina
  • 5.3. Rest of South America